Corcept Therapeutics Incorporated
CORT · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | July 30, 2026 | — | 219.13M | — | -0.04 | — |
| 2026 Q1 | April 30, 2026 | 164.90M | 185.27M | -0.30 | -0.30 | +10.53% |
| 2025 Q4 | February 24, 2026 | 202.13M | 254.94M | 0.20 | 0.27 | -0.71% |
| 2025 Q3 | November 4, 2025 | 207.64M | 255.35M | 0.16 | 0.18 | +7.81% |
| 2025 Q2 | July 31, 2025 | 194.43M | 244.58M | 0.29 | 0.23 | +2.72% |
| 2025 Q1 | May 5, 2025 | 157.21M | 216.68M | 0.17 | 0.17 | -4.33% |
| 2024 Q4 | February 26, 2025 | 181.89M | 200.12M | 0.26 | 0.37 | -5.55% |
| 2024 Q3 | October 30, 2024 | 182.55M | 198.02M | 0.41 | 0.27 | +4.44% |
| 2024 Q2 | July 29, 2024 | 163.80M | 162.08M | 0.32 | 0.23 | -1.12% |
| 2024 Q1 | May 1, 2024 | 146.81M | 141.20M | 0.25 | 0.21 | +4.94% |
| 2023 Q4 | February 15, 2024 | 135.41M | 129.30M | 0.28 | 0.25 | -7.15% |
| 2023 Q3 | November 1, 2023 | 123.60M | 127.82M | 0.28 | 0.22 | -9.97% |
| 2023 Q2 | August 2, 2023 | 117.72M | 109.69M | 0.25 | 0.15 | +24.91% |
| 2023 Q1 | May 3, 2023 | 105.65M | 104.87M | 0.14 | 0.20 | +3.90% |
| 2022 Q4 | February 28, 2023 | 103.06M | 105.08M | 0.14 | 0.23 | -4.66% |
| 2022 Q3 | November 3, 2022 | 101.73M | 107.57M | 0.30 | 0.23 | -10.41% |